621 related articles for article (PubMed ID: 34843666)
1. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
[TBL] [Abstract][Full Text] [Related]
2. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
Hurt W; Youngs J; Ball J; Edgeworth J; Hopkins P; Jenkins DR; Leaver S; Mazzella A; Molloy SF; Schelenz S; Wise MP; White PL; Yusuff H; Wyncoll D; Bicanic T
Thorax; 2023 Dec; 79(1):75-82. PubMed ID: 37657925
[TBL] [Abstract][Full Text] [Related]
5. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
[TBL] [Abstract][Full Text] [Related]
7. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
11. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
[TBL] [Abstract][Full Text] [Related]
12. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
13. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography.
Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
16. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
17. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
Iacovelli A; Oliva A; Mirabelli FM; Giannone S; Laguardia M; Morviducci M; Nicolardi ML; Repaci E; Sanzari MT; Leanza C; Raponi G; Mastroianni C; Palange P
BMC Infect Dis; 2024 Apr; 24(1):392. PubMed ID: 38605300
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N;
Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426
[TBL] [Abstract][Full Text] [Related]
20. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Chong WH; Saha BK; Neu KP
Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]